Abstract
Immediate toxicity among Chinese patients undergoing adjuvant doxorubicin and cyclophosphamide for early breast cancer- a single institute experience with comparison to historic Western series
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have